⌘K
Loading ticker…
As of 2026-08-25, Beta Bionics, Inc. Common Stock (BBNX) has a 3-month relative strength percentile of 96 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 59. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 8.6%, relative volume 0.47×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
BBNX is held by 16 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $2M notional. Top 3 carry $5M.
Held by 29 ETFs · $41M across latest filings · largest weight 1.10% (XHE).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $2M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $2M | — |
| SNSR | 0.25% | $623K | +0.04 pp |
| VTWG | 0.02% | $390K | — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $282K | — |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.08% |
| $215K |
| +0.07 pp |
| AVSC | 0.00% | $133K | — |
| VTWV | 0.00% | $44K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $35K | — |
| ITWO | 0.01% | $22K | — |
Showing 10 of 16 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BBNX Jan avg: -26.92% median: -26.92% win: 50% σ: 39.16% n: 2 2025-01-31 → 2026-07-31 | BBNX Feb avg: -10.30% median: -10.30% win: 0% σ: 2.30% n: 2 2025-01-31 → 2026-07-31 | BBNX Mar avg: -31.15% median: -31.15% win: 0% σ: 14.82% n: 2 2025-01-31 → 2026-07-31 | BBNX Apr avg: -3.96% median: -3.96% win: 50% σ: 8.14% n: 2 2025-01-31 → 2026-07-31 | BBNX May avg: 37.42% median: 37.42% win: 100% σ: 26.30% n: 2 2025-01-31 → 2026-07-31 | BBNX Jun avg: 6.87% median: 6.87% win: 50% σ: 31.70% n: 2 2025-01-31 → 2026-07-31 | BBNX Jul avg: -1.40% median: -1.40% win: 50% σ: 23.64% n: 2 2025-01-31 → 2026-07-31 | BBNX Aug avg: 12.21% median: 12.21% win: 100% σ: 0.00% n: 1 2025-01-31 → 2026-07-31 (current) | BBNX Sep avg: 5.47% median: 5.47% win: 100% σ: 0.00% n: 1 2025-01-31 → 2026-07-31 | BBNX Oct avg: 36.99% median: 36.99% win: 100% σ: 0.00% n: 1 2025-01-31 → 2026-07-31 | BBNX Nov avg: 15.14% median: 15.14% win: 100% σ: 0.00% n: 1 2025-01-31 → 2026-07-31 | BBNX Dec avg: -2.78% median: -2.78% win: 0% σ: 0.00% n: 1 2025-01-31 → 2026-07-31 |